| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/27/2001 | WO2001071358A1 Method of screening for inhibitors of osteopontin |
| 09/27/2001 | WO2001071005A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 09/27/2001 | WO2001071004A2 Proteases |
| 09/27/2001 | WO2001070984A2 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 09/27/2001 | WO2001070945A1 Recombinant proteins containing shiga-like toxin and vascular endothelial growth factor fragments |
| 09/27/2001 | WO2001070807A2 G-protein associated molecules |
| 09/27/2001 | WO2001070766A2 Therapeutic anti-cytomegalovirus compounds |
| 09/27/2001 | WO2001070757A2 Thioketals and thioethers for inhibiting the expression of vcam-1 |
| 09/27/2001 | WO2001070754A1 Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors |
| 09/27/2001 | WO2001070753A1 Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors |
| 09/27/2001 | WO2001070746A1 Furoisoquinoline derivatives, process for producing the same and use thereof |
| 09/27/2001 | WO2001070738A2 Tri-aryl-substituted-ethane pde4 inhibitors |
| 09/27/2001 | WO2001070734A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 09/27/2001 | WO2001070733A2 Di-substituted iminoheterocyclic compounds |
| 09/27/2001 | WO2001070723A1 Benzothiophene derivatives and medicinal use thereof |
| 09/27/2001 | WO2001070720A2 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 09/27/2001 | WO2001070696A1 Nitroethenamine derivatives or salts thereof and pharmaceutical compositions containing the derivatives or the salts |
| 09/27/2001 | WO2001070695A1 Pyridine derivatives as inhibitors of p38 |
| 09/27/2001 | WO2001070693A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
| 09/27/2001 | WO2001070691A1 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 09/27/2001 | WO2001070690A1 Heterocyclic side chain containing metalloprotease inhibitors |
| 09/27/2001 | WO2001070682A2 Carbocyclic side chain containing metalloprotease inhibitors |
| 09/27/2001 | WO2001070674A1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 09/27/2001 | WO2001070673A2 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a) |
| 09/27/2001 | WO2001070668A2 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 09/27/2001 | WO2001070663A2 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 09/27/2001 | WO2001070253A1 Use of mia in immunotherapy |
| 09/27/2001 | WO2001070246A1 Use of lactic acid bacterium for the treatment of peritonitis |
| 09/27/2001 | WO2001070233A2 Apoptosis inhibiting composition comprising a 15-keto-prostaglandin or derivative thereof |
| 09/27/2001 | WO2001070232A1 Protease inhibitors |
| 09/27/2001 | WO2001070208A2 Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate |
| 09/27/2001 | WO2001070130A2 Compositions derived from modiolus modiolus and methods for making and using same |
| 09/27/2001 | WO2001032663A3 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 09/27/2001 | WO2001032654A3 Novel heterocyclic compounds and their use as medicines |
| 09/27/2001 | WO2001030754A3 Micro-cluster liquids and methods of making and using them |
| 09/27/2001 | WO2001019973A3 Nicotinic acetylcholine receptor: alpha10 subunit |
| 09/27/2001 | WO2001019829A3 Pyrazolopyrimidines as therapeutic agents |
| 09/27/2001 | WO2001019320A3 Phospholipid prodrugs of anti-proliferative drugs |
| 09/27/2001 | WO2001017558A3 Novel uses of mammalian ccr6 receptors and related reagents |
| 09/27/2001 | WO2001016170A3 Card proteins involved in cell death regulation |
| 09/27/2001 | WO2001012606B1 Tetrahydroquinoline derivatives having retinoid-like biological activity |
| 09/27/2001 | WO2001009178A3 Human chaperone proteins |
| 09/27/2001 | WO2000061541A3 Pharmaceutical compounds |
| 09/27/2001 | WO2000041707A3 USE OF $i(LACTOBACILLUS SALIVARIUS) |
| 09/27/2001 | US20010025057 Containing nitric oxide donar containing nitroglycerin, glycol dinitrate, isopropyl nitrate, glyceryl-1,3-dinitrate, glyceryl-1,2-dinitrate, butane-1,2,4-triol-trinitrate, erythrityl teteranitrate, pentaerithrityl tetetranitrate etc. |
| 09/27/2001 | US20010025044 A bicyclic nitrogen containing heteroaromatic compound useful for inhibiting protein kinase p38 which involved in cell proliferation, cell death and response to extracellular stimuli |
| 09/27/2001 | US20010025041 Amidino protease inhibitors |
| 09/27/2001 | US20010025039 Tricyclic aza-indolyl derivatives substituted with ethylamine group is useful for treating central nervous system disorder,cardiovascular disorder, gastrointestinal disorders, diabetes insipidus, and particularly useful for obesity |
| 09/27/2001 | US20010025036 Modifying the structure of a 1alpha-hydroxylated vitamin D compound to increase its in vivo activity by altering the conformational equilibrium of the A-ring to favor a chair conformation that presents 1alphahydroxy in axial orientation |
| 09/27/2001 | US20010025029 Novel stromelysin inhibitors |
| 09/27/2001 | US20010024813 Human dendriac and brainiac-3 |
| 09/27/2001 | US20010024786 Purified polypeptide of given sequence; useful in diagnosis, prevention, and treatment of cancer, inflammation, and disorders of fatty acid metabolism |
| 09/27/2001 | US20010024664 Alzheimer's diseases; central nervous system disorders; antiinflammatory agent; solvent extraction from plants |
| 09/27/2001 | US20010024658 A delayed release pharmaceutical dosage form for oral administration of heparin comprising a low molecular weight heparin, a bile salt or acid, and a surfactant selected from hydrophilc and lipophilic, and a means for sustained release |
| 09/27/2001 | US20010024648 Four monkey monoclonal antibodies 7B6, 16C10, 7C10 and 20C9 which inhibit the B7:CD28 pathway and thereby function as effeftive immunosuppressants for the treatment of autoimmune diseases and prevent organ trasplant rejection |
| 09/27/2001 | US20010024642 A chewing gum that includes a gum center and a coating that substantially surrounds the center, comprises at least 50% by weight of chewing gum, the coating includes medicine; chewing the gum, causes the drug release, in patients buccal cavity |
| 09/27/2001 | DE10046728C1 New mercaptomethyl-substituted tricyclic quinazolinone derivatives, are matrix metalloprotease inhibitors useful for treating cancer, rheumatism, inflammatory reactions or allergies |
| 09/27/2001 | DE10014645A1 New amidino-aryl substituted biphenyl derivatives and analogs as Factor Xa inhibitors, are useful for treating thrombosis, myocardial infarction, arteriosclerosis, inflammation, apoplexy or angina pectoris |
| 09/27/2001 | DE10012120A1 New ligand, comprising therapeutic or diagnostic agent bonded non-covalently with substance having high affinity to transport molecule |
| 09/27/2001 | CA2406993A1 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 09/27/2001 | CA2404236A1 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 09/27/2001 | CA2404226A1 Furoisoquinoline derivatives, process for producing the same and use thereof |
| 09/27/2001 | CA2404206A1 Protease inhibitors |
| 09/27/2001 | CA2404131A1 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 09/27/2001 | CA2404076A1 Heterocyclic side chain containing metalloprotease inhibitors |
| 09/27/2001 | CA2403828A1 Inhibitors of p38 |
| 09/27/2001 | CA2403823A1 Thioketals and thioethers for inhibiting the expression of vcam-1 |
| 09/27/2001 | CA2403805A1 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 09/27/2001 | CA2403778A1 Carbocyclic side chain containing metalloprotease inhibitors |
| 09/27/2001 | CA2403681A1 Therapeutic anti-cytomegalovirus compounds |
| 09/27/2001 | CA2403671A1 Compositions derived from modiolus modiolus and methods for making and using same |
| 09/27/2001 | CA2403553A1 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 09/27/2001 | CA2403491A1 Use of lactic acid bacterium for the prevention of peritonitis |
| 09/27/2001 | CA2402763A1 Proteases |
| 09/27/2001 | CA2402747A1 G-protein associated molecules |
| 09/27/2001 | CA2402596A1 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 09/27/2001 | CA2402414A1 Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors |
| 09/27/2001 | CA2401984A1 Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors |
| 09/27/2001 | CA2401870A1 Cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-.alpha. |
| 09/27/2001 | CA2401728A1 Difluorobutyric acid metalloprotease inhibitors |
| 09/27/2001 | CA2400168A1 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 09/27/2001 | CA2399028A1 Use of mia in immunotherapy |
| 09/27/2001 | CA2364268A1 Di-substituted iminoheterocyclic compounds |
| 09/26/2001 | EP1136547A2 Adamts polypeptides, nucleic acids encoding them, and uses thereof |
| 09/26/2001 | EP1136488A1 Sf2809-i, ii, iii, iv, v and vi substances exhibiting chymase-inhibiting activities |
| 09/26/2001 | EP1135688A2 Methods and compositions useful for targeting activated vitronectin receptor alpha(nu)-beta(3) |
| 09/26/2001 | EP1135504A2 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 09/26/2001 | EP1135498A1 Antibody variants with higher binding affinity compared to parent antibodies |
| 09/26/2001 | EP1135496A2 Ucp5 |
| 09/26/2001 | EP1135495A2 Secreted amd transmembrane polypeptides and nucleic acids encoding the same |
| 09/26/2001 | EP1135494A2 Neuron-associated proteins |
| 09/26/2001 | EP1135490A1 Human vanilloid receptors and their uses |
| 09/26/2001 | EP1135486A1 RECOMBINANT SOLUBLE Fc RECEPTORS |
| 09/26/2001 | EP1135484A2 Gtpase associated proteins |
| 09/26/2001 | EP1135481A1 New oligomeric conjugates liable to transfer biological molecules into cells |
| 09/26/2001 | EP1135477A1 Humanized monoclonal antibodies |
| 09/26/2001 | EP1135417A1 Polysaccharide chiral esters, one of the methods for preparing them and their uses for obtaining optically enriched acids or chiral chromatography |
| 09/26/2001 | EP1135415A1 Humanized antibodies to gamma-interferon |
| 09/26/2001 | EP1135413A2 Proteins that bind angiogenesis-inhibiting proteins, compoisitions and methods of use thereof |
| 09/26/2001 | EP1135412A2 Tumor necrosis factor receptor homologue-1 (trh1) |